{"organizations": [], "uuid": "2f83398452e5a062a7055a2b01ef4c8ead4c163f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180121.html", "section_title": "Archive News &amp; Video for Sunday, 21 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cynata-therapeutics-seeks-trading/brief-cynata-therapeutics-seeks-trading-halt-idUSFWN1PE1A5", "country": "US", "domain_rank": 408, "title": "BRIEF-Cynata Therapeutics Seeks Trading Halt", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.049, "site_type": "news", "published": "2018-01-22T07:00:00.000+02:00", "replies_count": 0, "uuid": "2f83398452e5a062a7055a2b01ef4c8ead4c163f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cynata-therapeutics-seeks-trading/brief-cynata-therapeutics-seeks-trading-halt-idUSFWN1PE1A5", "ord_in_thread": 0, "title": "BRIEF-Cynata Therapeutics Seeks Trading Halt", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cynata therapeutics ltd", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 22 (Reuters) - Cynata Therapeutics Ltd:\n* SEEKS TRADING HALT PENDING ANNOUNCEMENT ‍IN RELATION TO DSMB REVIEW OF COHORT A OF COMPANY‘S PHASE 1 CLINICAL TRIAL Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-22T07:00:00.000+02:00", "crawled": "2018-01-22T20:42:41.005+02:00", "highlightTitle": ""}